The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
October 17th 2024
New findings show that undocumented Latinx immigrants, who make up 7% of the US population, face significant challenges in accessing health care due to uninsurance, limited access to care, language barriers, and fears surrounding their immigration status.
Real-World Data on Canagliflozin in Managed Care Setting Presented at ADA
June 8th 2015Patients who received canagliflozin from their health plan showed significant A1C improvement, even though the study group had poor glycemic control despite treatment with multiple therapies. The study period covered the months immediately following FDA approval.
Read More
Preventing Anthracycline-Related Late Cardiac Effects in Childhood Cancer Survivors
June 8th 2015In the United States, where 1 in 680 people between 20 and 50 years old are survivors of childhood cancer, the impact of long-term health consequences is a cause for concern, and even more so because this population is increasing.
Read More
Two Diet Studies, Two Approaches to Finding Keys to Weight Loss, Reduced Risk Factors
June 7th 2015Studies presented at the 2015 American Diabetes Association Scientific Sessions take different approaches on what percentage of carbohydrates should be part of a diet for persons with type 2 diabetes.
Read More
5-Year Follow-up After Lifestyle Intervention Examines Cardiovascular Effects of Keeping Weight Off
June 7th 2015Osama Hamdy, MD, PhD, and other researchers at Joslin Diabetes Center showed that patients with obesity and diabetes who lost at least 7% of their weight the first year stood a better chance of keeping it off.
Read More
Defining Value in Cancer Care Treatment
June 3rd 2015Participants on the second day of the National Comprehensive Cancer Network 20th Annual Conference in Hollywood, Florida, March 12-14, 2015, spent a long time defining value in cancer care and how it can be incorporated into healthcare decision making.
Read More
Augmenting the Immune System to Achieve Great Outcomes in Cancer Care
June 3rd 2015During the session "Principles of Immunotherapy" at the National Comprehensive Cancer Network 20th Annual Conference in Hollywood, Florida, Anthony J. Olszanski, RPh, MD, from the Fox Chase Cancer Center, described the complex interplay between the immune system and cancer.
Read More
To Test for PD-L1 or Not: the Jury's Still Out
June 2nd 2015Biomarker-directed regimens in cancer not only ensure treatment for the right patient population, it also makes economic sense, especially in today's climate of high-cost specialty medications like the novel immunooncology agents, nivolumab and pembrolizumab.
Read More
Advancing Patient Care in Cardio-Oncology: The ACC.15 Cardio-Oncology Intensive
June 2nd 2015A Cardio-Oncology Working Group formed by the ACC conducted a nationwide survey focused on cardio-oncology services, gathering opinions from cardiovascular division chiefs and fellowship training directors. This helped identify important challenges, including the need for broader educational opportunities and training.
Read More
Experts Discuss Medicare's New Oncology Care Model
June 2nd 2015The American Journal of Managed Care convened experts in health policy, from health plans, and from community oncology, to discuss OCM and other issues in oncology care during the Oncology Stakeholders Summit, Spring 2015 Peer Exchange.
Read More
Value of Patient-Reported Outcomes in Oncology Care
June 2nd 2015To discuss patient-reported outcomes and their importance in patient-centered care, The American Journal of Managed Care convened a panel of healthcare experts to participate in the Oncology Stakeholders Summit, Spring 2015 Peer Exchange.
Read More
Dr Luis A. Diaz Foresees Mismatched Repair Testing Implementation in Cancer Treatment
June 1st 2015Luis A. Diaz, Jr, MD, associate professor of oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, discovered that patients with high mutational burden with mismatched repair responded well to checkpoint inhibition of PD1.
Watch
Novel Options in Melanoma and Multiple Myeloma
June 1st 2015Much-anticipated trial results were presented on the third day of the annual meeting of the American Society of Clinical Oncology, held in Chicago. These included phase 3 results from the CheckMate 067 trial and a phase 2 study with elotuzumab.
Read More